Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 9, 1997 - Issue 1
21
Views
4
CrossRef citations to date
0
Altmetric
Research Article

COMPLEMENT ACTIVATION AFTER IN VITRO ASBESTOS EXPOSURE CORRESPONDS TO OXIDANT GENERATION

Pages 31-42 | Published online: 01 Oct 2008
 

Abstract

Asbestos exposures are associated with the generation of oxygen-based free radicals. Such oxidants can affect an activation of the alternative complement pathway. This study tested the hypothesis that complement activation after in vitro exposure to asbestos corresponds to the capacity of the fibers to catalyze oxidant generation. After incubation with 1.0 mM H2O2 and 1.0 mM ascorbate, the oxidation of 1.0 mM deoxyribose by 1.0 mg/ml crocidolite was diminished by both the metal chelator deferoxamine (1.0 mM) and the hydroxyl scavenger dimethylthiourea (DMTU) (10.0 mM). Similarly, elevations in [C5b-9] after incubations of plasma with 1.0 mg/ml crocidolite were diminished by inclusion of either 1.0 mM deferoxamine or 10.0 mM DMTU in the reaction mixtures. Pretreatment of crocidolite with deferoxamine to decrease chelatable iron concentrations and the capacity of the dust to generate oxidants resulted in less activation of complement after incubation with plasma. It is concluded that in vitro complement activation by crocidolite is associated with iron-catalyzed oxidant generation by these fibers.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.